Europe - Frankfurt Stock Exchange - FRA:W8A - US9314271084 - Common Stock
The current stock price of W8A.DE is 10.282 EUR. In the past month the price increased by 2.02%. In the past year, price increased by 23.31%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| RDC.DE | REDCARE PHARMACY NV | N/A | 1.39B |
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. The company is headquartered in Deerfield, Illinois and currently employs 193,000 full-time employees. The company went IPO on 2014-12-31. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The firm's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
Walgreens Boots Alliance Inc
108 Wilmot Rd
Deerfield ILLINOIS US
Employees: 252500
Phone: 18473152500
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. The company is headquartered in Deerfield, Illinois and currently employs 193,000 full-time employees. The company went IPO on 2014-12-31. The Company’s segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, and the Benavides brand in Mexico. The firm's U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
The current stock price of W8A.DE is 10.282 EUR. The price increased by 0.55% in the last trading session.
W8A.DE does not pay a dividend.
W8A.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on W8A.DE.
Walgreens Boots Alliance Inc (W8A.DE) has a market capitalization of 8.90B EUR. This makes W8A.DE a Mid Cap stock.
Walgreens Boots Alliance Inc (W8A.DE) will report earnings on 2025-10-13, after the market close.
ChartMill assigns a technical rating of 7 / 10 to W8A.DE. When comparing the yearly performance of all stocks, W8A.DE is one of the better performing stocks in the market, outperforming 77.32% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to W8A.DE. Both the profitability and financial health of W8A.DE have multiple concerns.
Over the last trailing twelve months W8A.DE reported a non-GAAP Earnings per Share(EPS) of 1.63. The EPS decreased by -39.56% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.07% | ||
| ROE | -87.68% | ||
| Debt/Equity | 1.09 |
11 analysts have analysed W8A.DE and the average price target is 10.21 EUR. This implies a price decrease of -0.75% is expected in the next year compared to the current price of 10.282.
For the next year, analysts expect an EPS growth of -38.04% and a revenue growth 6.29% for W8A.DE